Efficacy of lung surfactant combined with budesonide in improving bronchopulmonary dysplasia and growth of very low birth weight infants
BackgroundThere is few treatments for bronchopulmonary dysplasia (BPD), and systemic glucocorticoid therapy has serious side effects.MethodsLow birth weight infants were classified randomly into control group administered with pulmonary surfactant (200 mg/kg) and intervention group administered with...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2025-11-01
|
| Edice: | Frontiers in Pediatrics |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fped.2025.1686811/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|